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The GCM family of transcription factors consists of Drosophila melanogaster GCM, an important regulator
of gliogenesis in the fly, and its two mammalian homologs, GCMa and GCMb. To clarify the function of these
mammalian homologs, we deleted GCMa in mice. Genetic ablation of murine GCMa (mGCMa) is embryonic
lethal, with mice dying between 9.5 and 10 days postcoitum. At the time of death, no abnormalities were
apparent in the embryo proper. Nervous system development, in particular, was not impaired, as might have
been expected in analogy to Drosophila GCM. Instead, placental failure was the cause of death. In agreement
with the selective expression of mGCMa in labyrinthine trophoblasts, mutant placentas did not develop a
functional labyrinth layer, which is necessary for nutrient and gas exchange between maternal and fetal blood.
Only a few fetal blood vessels entered the placenta, and these failed to thrive and branch normally. Labyrin-
thine trophoblasts did not differentiate. All other layers of the placenta, including spongiotrophoblast and
giant cell layer, formed normally. Our results indicate that mGCMa plays a critical role in trophoblast
differentiation and the signal transduction processes required for normal vascularization of the placenta.
Drosophila melanogaster Glial Cells Missing (GCM) (15, 18,
39) and its mammalian homologs, GCMa/GCM1 and GCMb/
GCM2 (1, 3), form a small family of transcription factors. The
defining feature of these proteins is a highly conserved domain
in the amino-terminal region which has been referred to as the
gcm box and constitutes the DNA-binding domain (1, 32). The
close resemblance of the DNA-binding domains is also re-
flected in the very similar DNA-binding specificities of GCM
proteins (31, 36). Additional structural features shared by
GCM proteins include the presence of a transactivation do-
main in the extreme carboxy terminus and high turnover rates
with half-lives ranging between 0.5 h (for GCMb) and 2 h (for
GCMa) (29, 32, 36).
The function of Drosophila GCM is understood quite well. It
is expressed in both the hemocyte lineage (8) and the devel-
oping nervous system (15, 18, 39). In the latter, GCM expres-
sion is restricted to prospective glial cells. In fact, GCM is by
far the earliest marker for glial cells in Drosophila, and analysis
of mutant flies has shown that GCM is both necessary and
sufficient to induce glial fate in an uncommitted neural pre-
cursor (15, 18, 39). GCM thus functions as a master regulator
of gliogenesis in Drosophila.
If one assumes that generation of glial cells from neural
precursors is mediated by an evolutionarily conserved mecha-
nism, one might expect that mammalian GCM homologs
would also play a role in the generation of glial cells through-
out the mammalian nervous system (4). Backing this hypoth-
esis, ectopic expression of a GCMa transgene in the developing
nervous system of Drosophila led to a significant increase in
glial cells at the expense of neurons (21, 29). GCMb failed to
cause a comparable neuron-to-glia transformation under sim-
ilar experimental conditions (21).
However, expression of both GCMa and GCMb in the mam-
malian nervous system was detected only by sensitive PCR
methods (3, 6, 21). The only site where expression of GCMb
was readily detectable was the developing parathyroid (21).
GCMa was primarily detected in the developing placenta (3, 6,
17, 21). Here, GCMa expression started early in the chorion
(6). During development of the placenta, the chorion collapses
onto the ectoplacental cone and fuses with the allantois to
develop into the labyrinth. The labyrinth functions as the site
of gas and nutrient exchange between fetal and maternal blood
once the yolk sac circulation can no longer meet the increasing
metabolic demand of the embryo. To that end, the labyrinth
contains juxtaposed maternal blood sinuses and fetal blood
vessels separated only by a three-cell-layered barrier of par-
tially syncytial labyrinthine trophoblasts. Fetal blood vessels
are derived from the allantoic mesenchyme, whereas the lab-
yrinthine trophoblasts stem from the chorion. Trophoblasts of
the labyrinth layer express murine GCMa (mGCMa), as do
their chorionic precursors (6). Expression decreases only after
15.5 days postcoitum (d.p.c.) but remains detectable until
17.5 d.p.c.
Expression patterns of GCMa and GCMb are more com-
patible with a function of mammalian GCM proteins outside
the nervous system. To clarify the function of mammalian
GCM proteins, we deleted the GCMa gene by targeted mu-
tagenesis in mice. Here we report that genetic ablation of
GCMa leads to early embryonic lethality which results from
placental defects, in particular from a failure of labyrinth layer
formation.
MATERIALS AND METHODS
Construction of targeting vector. Genomic sequence from the GCMa locus of
129/Sv mice was obtained by screening a lambda phage library. A 2.2-kb NotI/
NruI PCR fragment starting in intron 1 and ending in exon 3 was used as 59
homology region and was placed in front of a lacZ marker such that a continuous
open reading frame was generated between the 32 amino-terminal residues of
GCMa and LacZ. A 3.8-kb EcoRI fragment downstream of the known untrans-
lated region of exon 6 was used as 39 homology region. Both the combination of
59 homology region and lacZ and the 39 homology region were inserted in
pPNT(37) on either side of the neomycin resistance cassette (Fig. 1A). The
targeting vector thus replaced the complete open reading frame of GCMa down-
stream of amino acid 32 with a lacZ marker gene (Fig. 1B). The construct was
linearized with NotI before electroporation.
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Gene targeting and generation of mouse mutants. The linearized construct
was electroporated into R1 embryonic stem (ES) cells which were then selected
with G418 (200 mg per ml) and ganciclovir (2 mM). Selected ES cell clones were
screened by Southern blotting with a 0.4-kb 59 probe, which recognizes a 7.1-kb
fragment in the case of the wild-type allele and an 8.2-kb fragment in the case of
the targeted allele in genomic DNA digested with HindIII (Fig. 1A and B). Four
clones among the 150 tested exhibited the pattern expected for homologous
recombination of one allele. Appropriate integration of the 39 end of the tar-
geting construct was verified in the four positive clones using a 1.2-kb 39 probe
on PvuII-digested ES cell DNA. This probe hybridized to a 7.3-kb fragment in
the targeted allele as opposed to a 7.6-kb fragment in the wild-type allele (Fig.
1A and B). Hybridization with a neo probe confirmed that only a single integra-
tion event had occurred. Two targeted ES cell lines were injected into blastocysts
to generate chimeras. Chimeric males from two independent clones transmitted
the targeted allele to their offspring. No differences were detected between mice
derived from the two different ES cell lines. Homozygous mutant embryos were
generated by heterozygote intercrosses. Genotyping was routinely performed by
PCR analysis using a common upper primer located at the border of intron 2 and
exon 3 (59CAGAACGTGAAAACGACTGACTGG39) and two lower primers
located within exon 3 (59CACTCTGCTGCTTCTGTCTGGCTT39) and lacZ
(59GATAGGTTACGTTGGTGTAGATGG39), respectively. DNA was ob-
tained from tail tips or, in the case of embryos, from yolk sacs. PCR was
performed in 30-ml reaction mixtures containing standard buffer and 0.5 mM
(each) primer. The cycling conditions consisted of an initial 2-min denaturing
step at 94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 65°C, and 30 s at 72°C.
A 260-bp fragment was indicative of the wild-type allele, and a 350-bp fragment
was indicative of the targeted allele.
In situ hybridization, lacZ staining, histology, and microscopy. Entire concep-
tus and placentas were isolated at 8.5 to 13.5 d.p.c. from staged pregnancies.
Staining for b-galactosidase activity was performed essentially as described pre-
viously (14). After fixation for 2 h in 4% paraformaldehyde, material was incu-
bated at 37°C in 1% X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside)
for 1 to 6 h.
For in situ hybridization, placentas were fixed overnight at 4°C in 4% para-
formaldehyde, dehydrated, bleached, rehydrated, and embedded in 20% gelatin.
After a second overnight fixation in 4% paraformaldehyde, placentas were sec-
tioned on a vibrating-blade microtome (vibratome) (100 mm). Digoxigenin-la-
beled riboprobes were produced with a digoxigenin-RNA labeling kit (Roche
Diagnostics). Whole-mount in situ hybridization on vibratome slices was per-
formed essentially as described previously (41) with probes for Flt1 (23), germ
cell nuclear factor (GCNF) (34), and Dlx3 (28).
For histological analysis, placentas were fixed overnight at 4°C in 4% parafor-
maldehyde, dehydrated, and embedded in Technovit 7100 resin (Kulzer); 6-mm
sections were stained with eosin-hematoxylin or with eosin only in the case of
prior b-galactosidase staining.
RESULTS
Targeted mutagenesis of mGCMa. The mGCMa gene was
targeted by homologous recombination in R1 ES cells with a
vector that replaced most of exon 3 as well as exons 4 to 6 with
the lacZ open reading frame followed by a neomycin selection
cassette (Fig. 1A). Transcription of the neomycin resistance
gene was in the same direction as transcription of mGCMa,
and insertion of the lacZ gene was such that its open reading
frame was fused in frame with the amino-terminal 32 residues
of mGCMa (Fig. 1B). Because all other mGCMa residues were
removed, the resulting mutant allele is null. ES cell clones in
which homologous recombination of one allele had occurred
were identified by Southern blot analysis with probes flanking
the sequence included in the targeting vector (Fig. 1C). Two
independent recombinant ES cell clones were used to generate
chimeric mice. Germ line transmission was achieved with chi-
meras from both ES cell clones as evident from Southern blots
(Fig. 1C), and identical results were obtained with mice ob-
tained from both ES cell clones.
Heterozygous mice were viable and fertile. In matings of
heterozygous to wild-type mice, the mutant allele was detected
in approximately 50% of progeny (data not shown). They ex-
hibited no obvious phenotypic defects. These results suggest
that heterozygosity of mGCMa is phenotypically inapparent
and that mGCMa is not imprinted.
Matings of heterozygous pairs, however, did not generate
any live births of homozygous mutant mice. Thus, loss of both
mGCMa alleles is embryonic lethal. To identify the time of
FIG. 1. Targeted disruption of mGCMa in mice. (A) Schematic representation of the mGCMa wild-type locus (top) and the targeting vector (bottom). mGCMa
exons are marked by Roman numerals. (B) Targeted mGCMa allele. Localizations of the probes and the diagnostic restriction fragments before and after homologous
recombination are shown. (C) Southern blot analysis of DNA from ES cells (ES) and 9.5-day-old mouse embryos (9.5 d.p.c.) digested with HindIII for use of the 59
probe and PvuII for use of the 39 probe. The positions of bands corresponding to the wild-type allele (wt) and the targeted allele (rec) are indicated. (D) Macroscopic
appearance of mutant (I and III) and wild-type (II and IV) embryos recovered at 9.5 (I and II) and 11.5 (III and IV) d.p.c.
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death, embryos derived from heterozygous intercrosses were
genotyped at various stages of gestation and phenotypically
analyzed. At 9.5 d.p.c., homozygous embryos were detectable
(Fig. 1C). They were alive and present in the expected Men-
delian frequency (Table 1). Their phenotypic appearance was
indistinguishable from that of wild-type and heterozygous lit-
termates (Fig. 1D, I and II). Their yolk sac appeared histolog-
ically normal. At 10.5 d.p.c., homozygous embryos were still
present in expected numbers but dead (Table 1). The number
of somites in homozygous mutant embryos indicated that fetal
death occurred between 9.5 and 10 d.p.c. No gross abnormal-
ities were detectable in the embryo proper up to the time of
death. At 11.5 d.p.c., the homozygous mutant embryos were
already smaller and showed signs of resorption (Fig. 1D, III
and IV).
At this developmental stage, no mGCMa expression could
be detected in the embryo proper (data not shown). There is,
however, a strong expression of mGCMa in parts of the devel-
oping placenta from 7.5 d.p.c. onwards (3, 6, 21). Expression is
restricted to extraembryonic ectoderm, in particular chorionic
trophoblast and later trophoblast cells of the labyrinth (6).
Exclusive expression in trophoblasts and the absence of gross
morphological abnormalities in mutant embryos at the time of
their death pointed to a placental defect.
Placental morphology of mGCMa knockout mice. Gross
morphological examination of the placenta at 8.5 d.p.c. re-
vealed no significant difference between homozygous mutant
and wild-type mice (Fig. 2A and B). The chorion had collapsed
onto the ectoplacental cone, and fusion between chorion and
allantois had occurred. At this level of resolution, mutant pla-
centas still looked fairly normal at 9.5 d.p.c. (Fig. 2C and D).
By 10.5 and 11.5 d.p.c., abnormalities were clearly evident in
the mutant placenta. The wild-type placenta had acquired the
typical three-layered appearance with the labyrinth layer being
the inner layer, the spongiotrophoblast being the middle layer,
and the giant cells forming the outer layer and interface with
the maternal decidua (Fig. 2F and H). Spongiotrophoblast and
giant cell layer appeared normal in the homozygous placenta.
The region corresponding to the labyrinth layer, however, ex-
hibited a severe reduction in thickness (Fig. 2E and G). The
overall shape of the placenta had changed due to the substan-
tial size reduction of the labyrinth such that the majority of
mutant placentas after being cut in half had a convex rather
than a concave shape.
A more detailed histological analysis under higher magnifi-
cation confirmed and extended these observations (Fig. 3).
At higher resolution, defects became apparent earlier. At
9.5 d.p.c., chorionic trophoblasts were found densely packed at
the base of the placenta in homozygous mutant embryos (Fig.
3A), whereas chorionic trophoblasts in age-matched wild-type
and heterozygous placentas had already started to spread in-
wards and participate in the formation of the labyrinth layer
together with the angiogenic allantoic mesenchyme (Fig. 3B).
Fetal blood vessels, identified by their containing nucleated
embryonic blood cells, started entering the prospective laby-
rinth from the base. Their number was strongly reduced in
mutant placentas compared to normal placentas (compare Fig.
4A to B). Those fetal blood vessels that were detected in the
mutant were either outside the placenta or—when in the pla-
centa—had formed exclusively near the base where the sur-
rounding trophoblast tissue was very compact (Fig. 4A). In
contrast to the normal placenta (compare with Fig. 4B), fetal
blood vessels in the mutant placenta were never found in the
immediate vicinity of maternal blood sinuses. These developed
normally. The tight apposition of fetal blood vessels and ma-
ternal sinuses seen in the normal placenta is, however, a key
prerequisite for the function of the labyrinth in the exchange of
gas and nutrients between fetal and maternal blood.
At 10.5 d.p.c., the typical structure of the labyrinth was
already visible in wild-type mice (Fig. 3D). In homozygous
mutant mice, there was a drastic reduction in the size of this
layer, and the number of cells in the mutant layer was de-
creased. The lower cell number and the invading maternal
blood sinuses had given parts of the layer a sponge-like ap-
pearance (Fig. 3C). Near the base of the placenta, the layer
FIG. 2. Effects of mGCMa ablation on placental morphology. Transverse
sections (6 mm) of Technovit-embedded placentas stained with eosin-hematox-
ylin at low magnification. (A, C, E, and G) Mutant. (B, D, F, and H) Wild type.
(A and B) 8.5 d.p.c. (C and D) 9.5 d.p.c. (E and F) 10.5 d.p.c. (G and H)
11.5 d.p.c. The labyrinth layer is marked by brackets. Note the altered shape of
the mutant placenta at later stages.
TABLE 1. Genotyping of offspring from mGCMa
heterozygous parents
Age (d.p.c.)
No. of offspring per type
Wild type Heterozygous Homozygous
8.5 2 5 1
9.5 14 27 11
10.5 9 14 10a
11.5 4 10 6a
12.5 4 4 1a
All 33 60 29
a Recovered embryos were dead.
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remained compact. By 10.5 d.p.c., fetal blood vessels were
completely missing from mutant placentas, whereas an intri-
cate network of fetal blood vessels had developed in juxtapo-
sition to maternal blood sinuses in normal placentas (compare
Fig. 4C to D). In the homozygous mutant, fetal blood vessels
were detected only on the outside of the placenta underlying
the compact layer of chorionic trophoblasts (Fig. 4E). The
elongated differentiated trophoblasts that form the hemotri-
chorial barrier around the fetal blood vessels were undetect-
able in the mutant placenta. With increasing developmental
age, amorphous material was detected throughout the mutant
placenta (shown for 12.5 d.p.c. in Fig. 4F). Such deposits were
absent from normal placentas. Even at this level of resolution,
the giant cell layer (Fig. 4G and H) and the spongiotrophoblast
layer appeared normal. If anything, there might have been a
slight hypertrophy of the spongiotrophoblast layer (Fig. 3C to
F).
As shown for 11.5 d.p.c., the same defects became even more
pronounced at later points in development with the labyrinth
layer growing significantly in size in normal placentas (Fig. 3F)
but keeping a constant size in mutant placentas (Fig. 3E). We
conclude from these observations that a functional labyrinth
layer never forms in the mutant and that the resulting failure to
supply the embryo with nutrients and oxygen is responsible for
the observed embryonic lethality.
Analysis of trophoblast marker gene expression in mutant
placentas. For a better characterization of the placental defect,
we next compared the expression of several trophoblast mark-
ers in mutant and normal placentas (Fig. 5). From 9.5 d.p.c.
onwards, the receptor tyrosine kinase Flt1 is a marker for the
spongiotrophoblast (23). At all embryonic stages examined,
Flt1 expression was very similar in normal and mutant placen-
tas (Fig. 5B, E, H, K, N, and Q). In agreement with morpho-
logical analysis, the Flt1-positive spongiotrophoblast layer
seemed on average slightly enlarged in mutant placentas.
Two markers were employed to study the labyrinth layer, in
particular its trophoblast component. Both the orphan nuclear
receptor GCNF and the mammalian Distal-less homolog Dlx3
are expressed in overlapping, but not identical, subsets of lab-
yrinthine trophoblast cells (28, 34). At 9.5 d.p.c., cells express-
ing Dlx3 or GCNF were detected in normal and mutant pla-
centas. In mutant placentas (Fig. 5A and C), they were
arranged in a more compacted layer than in normal placentas
(Fig. 5D and F). By 10.5 d.p.c., the area with Dlx3- and GCNF-
FIG. 3. Effects of mGCMa ablation on placental histology. Higher magnifi-
cation of transverse sections (6 mm) of Technovit-embedded mutant (A, C, and
E) and wild-type (B, D, and F) placentas at various developmental ages. (A and
B) 9.5 d.p.c. (C and D) 10.5 d.p.c. (E and F) 11.5 d.p.c. Localizations of labyrinth
layer (l), spongiotrophoblast layer (s), and maternal decidua (d) are indicated.
Large cell-free areas in the abnormal labyrinth layer of the mutant are marked
by arrows.
FIG. 4. Placental anomalies in mGCMa-deficient conceptus. Transverse sec-
tions (6 mm) of Technovit-embedded placentas. At 9.5 d.p.c. (A and B), few fetal
blood vessels (arrowheads) were found within the prospective labyrinth of the
mutant placenta (A) compared to the wild-type placenta (B). Maternal blood
sinuses (arrows) were present in normal numbers but were never close to em-
bryonal vessels at any time during development as observed for the wild type (B
and D). At 10.5 d.p.c. (C to E), fetal blood vessels (arrowheads) were present in
the labyrinth of normal placentas (D) but absent from the mutant (C) and were
detected only outside the placenta (E). Amorphous material (am) was frequently
deposited within the labyrinth layer of mutant placentas (12.5 d.p.c. in panel F).
Giant cells (gl) are indistinguishable between mutant (G) and wild type (H) at
10.5 d.p.c. and later stages of development.
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expressing cells had expanded substantially in the normal pla-
centa as expected for the labyrinth layer (Fig. 5J and L). The
speckled distribution of the hybridization signal indicated that
within the labyrinth Dlx3- and GCNF-positive trophoblasts
had intermingled with Dlx3- and GCNF-negative cells derived
from the allantoic mesenchyme. In contrast, Dlx3- and GCNF-
expressing cells had remained in a narrow, compact layer in
mutant placentas (Fig. 5G and I). Staining of this layer was
uniform, indicating the absence of significant numbers of in-
terspersed cells which did not express Dlx3 or GCNF. This
layer corresponded to the densely packed chorionic tropho-
blasts at the base of the placenta but also contained material
from the sponge-like structure between chorionic trophoblast
layer and spongiotrophoblast, as this structure is not preserved
during vibratome sectioning. These phenotypic changes were
even more apparent at 11.5 and 12.5 d.p.c. (Fig. 5M to R and
data not shown), indicating that the observed defect is of per-
manent rather than transient nature. In agreement with histo-
logical analyses, these results indicate that a typical labyrinth
structure never formed. Chorionic trophoblasts as defined by
expression of typical markers were, however, present in signif-
icant numbers in the absence of mGCMa expression.
Analysis of b-galactosidase expression in mutant placentas.
Inclusion of the lacZ coding sequence in our target construct
and its in-frame fusion with the amino terminus of mGCMa
allowed us to monitor the fate of mGCMa-expressing cells in
heterozygous normal and homozygous mutant placentas by
b-galactosidase staining (Fig. 6). b-Galactosidase activity was
already detected in chorionic trophoblasts around the time of
chorion-allantois fusion in both mutant and normal placentas
(Fig. 6A and B and data not shown). In the heterozygous
placenta, b-galactosidase-expressing cells increased steadily in
FIG. 5. Expression of placental markers. Transverse sections (100 mm) of
paraformaldehyde-fixed placentas were hybridized with GCNF, Flt1, and Dlx3
probes as indicated. Analyzed were mutant (A to C, G to I, and M to O) and
wild-type (D to F, J to L, and P to R) placentas from 9.5 (A to F), 10.5 (G to L),
and 11.5 (M to R) d.p.c. Localizations of spongiotrophoblast (s) and labyrinth
layer (l) are indicated.
FIG. 6. b-Galactosidase staining of normal and mutant placentas. Parafor-
maldehyde fixed placentas were transversely cut in half at 8.5 (A and B), 9.5 (C
to F), 10.5 (G to J), and 11.5 (K to N) d.p.c. and stained for b-galactosidase
activity. A view from the sectioned side is shown in low (A, C, D, G, H, K, and
L) and high (B, E, F, I, J, M, and N) magnification for both heterozygous normal
(A, B, D, F, H, J, L, and N) and homozygous mutant (C, E, G, I, K, and M)
placentas.
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number up to 11.5 d.p.c. and were spread over the whole area
of the labyrinth (Fig. 6D, F, H, J, L, and N). Variations in
staining intensities in different parts of the labyrinth indicated
that b-galactosidase expression was not uniform throughout
this layer, as already reported for GCNF and Dlx3 (Fig. 5).
This expression pattern is caused by selective b-galactosidase
expression in trophoblasts of the labyrinth and is very similar to
the in situ hybridization pattern observed for mGCMa. We
conclude that our lacZ marker faithfully mimicks the temporal
and spatial expression of mGCMa in the developing placenta.
Closer microscopic examination on thin sections indeed con-
firmed that lacZ is not expressed in mesenchymal components
of the labyrinth layer (Fig. 7B and D). In agreement with
previous in situ hybridization results using an mGCMa probe
(6), b-galactosidase was detected in two morphologically dis-
tinct types of labyrinthine trophoblast (Fig. 7D). The first were
cuboidal mononuclear cells. The second were elongated cells
of the three-cell-layered hemotrichorial barrier between fetal
blood vessels and maternal blood sinuses. Of the three layers,
the two closest to the fetal blood vessels consist of syncytial
trophoblasts whereas the layer closest to the maternal sinuses
is cellular. b-Galactosidase activity was higher in the syncytial
trophoblasts closest to the fetal blood vessels and compara-
tively lower in the cellular trophoblasts lining the maternal
blood sinuses. Expression in syncytial trophoblasts was also
corroborated by the diffuse appearance of the b-galactosidase
staining pattern. lacZ expression in the labyrinth layer re-
mained strong until 12.5 d.p.c., which was the last developmen-
tal age analyzed in our study.
Mutant placentas exhibited a vastly different lacZ expression
pattern. From 9.5 d.p.c., lacZ-expressing cells were strongly
reduced (Fig. 6C and E). Those lacZ-expressing cells that were
still present remained in the compact layer close to the base of
the placenta and did not spread into the prospective labyrinth
layer. Intriguingly, there were significantly fewer lacZ-express-
ing cells than GCNF- and Dlx3-expressing cells in the mutant
placenta, indicating that mGCMa is not essential for obtaining
the trophoblast fate. Up until 10.5 d.p.c., the lacZ expression
remained fairly stable, despite the fact that the placenta in-
creased dramatically in size during that same period (Fig. 6G
and I). Thus, lacZ-expressing cells persisted in the mutant
placenta until 10.5 d.p.c. or even slightly increased in number.
From 11.5 d.p.c. onwards, however, lacZ expression was hardly
detectable despite significant levels of Dlx3 and GCNF (Fig.
6K and M). Close inspection of thin sections furthermore re-
vealed that the lacZ-expressing cells in the mutant placenta
were confined to the compact layer at the inner side of the
placenta (Fig. 7A and C). They corresponded exclusively to
mononuclear, cuboidal cells, in agreement with the fact that
differentiated elongated trophoblasts were not detected in the
mutant placenta.
DISCUSSION
In this paper, we describe the result of targeted deletion of
the mGCMa gene. mGCMa is one of the two mammalian
homologs of the Drosophila GCM gene that have been iden-
tified in extensive searches over the last several years (1, 3, 6,
19–21, 31). Interest in these mammalian GCM homologs
stemmed from the expected role of these proteins as master
regulators of gliogenesis in mammals (4). The Drosophila
GCM had previously been shown to be the earliest regulator
involved in fate determination of glial cells (15, 18, 39). GCM
proved to be quite potent in that function as ectopic expression
of GCM resulted in transformation of cell fate towards a glial
fate, whereas loss of GCM expression invariably led to an
extensive loss of glial cells in both peripheral and central ner-
vous systems and a concomitant increase in neurons (2, 7, 15,
18, 39).
Given the fact that homologous proteins often have con-
served functions between species, it was expected that at least
one of the two mammalian GCM homologs has a role in
gliogenesis. Biochemical analyses and overexpression studies
in flies indicated that GCMa was a better candidate than
GCMb. For one thing, GCMa behaved much more like GCM
in transfection studies than did GCMb (29). Additionally,
GCMa was able to transform cells in the Drosophila embryo to
cells with a glial phenotype, whereas GCMb failed to do so (21,
29).
Thus, we were surprised by the result of genetic mGCMa
ablation. Instead of a defect in nervous system development,
we obtained a severe placental defect that led to early embry-
onic lethality between 9.5 and 10 d.p.c. At the time of death, no
major defects were detectable in the development of the ner-
vous system or any other parts of the embryo proper. In effect,
we were unable to detect expression of mGCMa in any part of
the embryo including the nervous system either by in situ
hybridization or by lacZ staining up until 13.5 d.p.c., which was
the latest developmental stage analyzed in this study. Cur-
rently, we cannot exclude a role of mGCMa in later stages of
nervous system development. This can be answered only by
tetraploid aggregation experiments. However, if there is a role
in nervous system development, it cannot be the one of a
master regulator or an early determination switch, because
glial progenitors are already formed and recognizable by
marker gene expression at 13.5 d.p.c. both in the peripheral
and in the central nervous system, i.e., at a time when mGCMa
expression cannot be detected in the embryo proper. Thus,
mGCMa does not seem to belong to those genes, in which
function has been conserved during evolution.
In other respects, the placental phenotype was not unex-
pected, as this is the only tissue in which significant mGCMa
expression had been detected by in situ hybridization analysis
(6, 21). mGCMa expression has been reported for extraembry-
onic ectoderm of the chorion as early as 7.5 d.p.c. (6). Later,
mGCMa expression is confined to the labyrinth layer of the
placenta and therein to labyrinthine trophoblasts. Allantois-
derived mesenchyme scores negative for mGCMa. The laby-
FIG. 7. High-resolution mapping of lacZ-expressing cells in the placenta.
Close microscopic examination of 6-mm sections from lacZ-stained placentas at
10.5 d.p.c. counterstained with eosin. (A and C) Homozygous mutant placenta;
(B and D) heterozygous normal placenta. Cuboidal mononuclear cells are
marked by arrows, and syncytial trophoblasts close to fetal blood vessels are
marked by arrowheads. mb, maternal blood sinus; fb, fetal blood.
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rinthine trophoblasts form a heterogenous population with two
morphologically distinct cell types, cuboidal mononuclear cells
which are believed to possess stem cell character (35) and
elongated cells that separate fetal vessels and the maternal
blood sinuses and are believed to represent the differentiated
labyrinthine trophoblast stage. mGCMa is expressed in both
the cuboidal and the elongated cells. This mGCMa expression
pattern is faithfully recapitulated by the lacZ marker that we
integrated into the mGCMa locus as part of our gene targeting
strategy down to the cellular level. We first observed lacZ
expression in the chorion around the time of chorion-allantois
fusion. Later on, the lacZ marker was exclusively expressed in
the trophoblast cells of the labyrinth. In heterozygous normal
placentas, we detected it in both cuboidal and elongated lab-
yrinthine trophoblasts. Thus, we believe that our lacZ marker
will provide a useful tool to study fate and lineage relationships
of labyrinthine trophoblasts. We can also conclude from our
observation that no essential regulatory regions are present
between exon 3 and exon 6 of mGCMa, as loss of this region
did not interfere with correct spatial and temporal expression
of the lacZ marker.
In accord with the strong and selective expression of
mGCMa in the labyrinth, we found a major defect in labyrinth
layer formation in the mGCMa knockouts which impaired
chorioallantoic circulation. This defect is sufficient to explain
the observed embryonic lethality. Due to their growing size,
mouse embryos start to depend on the chorioallantoic circu-
lation at 9.5 to 10 d.p.c., the exact time of death of the ho-
mozygous mutant embryos.
The defect in the labyrinth layer is not due to the loss of
either chorion or allantois. In fact, both form normally. Thus,
the defect in mGCMa knockouts occurs at a later stage than
the one in the Ets2 knockout, in which there are no detectable
chorion and allantoic membranes (22). Chorion and allantois
were not only present; they also fused. Chorion-allantois fusion
is an important prerequisite for formation of the labyrinth
layer which is disturbed in a number of other mouse models
with placental defects including knockouts for vascular cell
adhesion molecule 1, a4 integrin, Mrj, and the nuclear orphan
receptor Err2/Errb (12, 16, 25, 42).
Following chorion-allantois fusion, the labyrinth layer forms
with allantoic mesenchyme invading the placenta, forming the
fetal blood vessels, and trophoblasts forming the three-cell-
layered hemotrichorial barrier which separates fetal blood ves-
sels and maternal blood sinuses and mediating the nutrient
exchange. We observed severe anomalies in the establishment
and maintenance of the fetal vascular network in the mGCMa
knockouts. Allantoic blood vessels invaded the chorion in al-
ready dramatically reduced numbers, remained near the base
of the placenta, and failed to elaborate into the vascular net-
work typical of the labyrinth layer. By 10.5 d.p.c., fetal blood
vessels were essentially absent from the mutant placenta and
were detected only on the outside of the placental base.
In the normal placenta, trophoblasts and mesenchyme are
not only intricately intertwined within the labyrinth layer; they
also influence each other’s development. Allantoic blood ves-
sels induce the differentiation of the labyrinthine trophoblasts
into cells of the hemotrichorial barrier (13, 38). Labyrinthine
trophoblasts, on the other hand, express important mitogens
required for normal vasculogenesis such as vascular endothe-
lial growth factor (9). Defects in trophoblasts can therefore
affect the development of the allantoic mesenchyme (33) and
vice versa (38). With the absence of allantoic mesenchyme in
the prospective labyrinth of mGCMa-deficient mice, tropho-
blasts failed to differentiate into the hemotrichorium that nor-
mally surrounds the fetal blood vessels. Instead, trophoblasts
remained densely packed except in those regions invaded by
maternal blood sinuses. Although there was a clear reduction
in trophoblasts, significant numbers remained present and de-
tectable.
Other processes which take place in the developing placenta,
such as the formation of the secondary giant cells and the
spongiotrophoblast from the ectoplacental cone, remained un-
altered. If anything, there might have been a slight increase in
the size of the spongiotrophoblast as indicated both by histo-
logical analysis and by in situ hybridization with a spongiotro-
phoblast-specific probe. However, given the fact that mGCMa
was not found to be expressed in the spongiotrophoblast at any
time of development, it seems likely that possible minor effects
on spongiotrophoblast development are non-cell-autonomous
and secondary to defects in the labyrinth layer.
Other mouse mutants have been described that exhibit de-
fects in labyrinth layer formation. In the Mash-2 mutant, for
instance, the labyrinth is not properly vascularized (11). How-
ever, in this case, it was shown that the labyrinth defect is
secondary to a failure of the spongiotrophoblast to form be-
cause of the defective development of diploid stem cells in the
ectoplacental cone (35).
In the RXRa-RXRb double knockouts, the defect is intrin-
sic to the labyrinth layer (40). In this case, a markedly de-
creased proliferation and hence shortage of diploid tropho-
blast cells is responsible for labyrinth agenesis. After deletion
of the Von Hippel-Landau tumor suppressor, allantoic vessels
fail to enter the chorion altogether (10).
The phenotype of Dlx3-deficient mice shares obvious simi-
larities to the phenotype described here for mGCMa in the
time of embryonic death, the reduced vascularization, and the
compact morphology of the labyrinth (28). The similarities in
phenotypes are not unexpected, as both transcription factors
are expressed in the same cell type in a temporally and spatially
overlapping pattern. However, there are also differences be-
tween the two types of knockout mice. In addition to the
labyrinth defect, Dlx3-deficient mice show a severe reduction
in the size of the spongiotrophoblast layer, which was unaf-
fected or even increased in size after genetic ablation of
mGCMa. Furthermore, we never observed in GCMa-deficient
mice the alterations in marker gene expression described in
reference 28 for the Dlx3 knockouts. These phenotypic differ-
ences are paralleled by differences in expression. Especially
during early phases of labyrinth formation, there are many
more trophoblasts expressing Dlx3 than GCMa, with GCMa
expression increasing only at later times. Thus, Dlx3 expression
is possible in the absence of GCMa, arguing that both tran-
scription factors are regulated differently in the same group of
cells and likely perform separate functions.
Mice deficient for nuclear receptor PPARg and the basic
helix-loop-helix transcription factor Tfeb have the phenotype
most similar to our GCMa knockout mice (5, 33). Fetal blood
vessels invade the placenta, but rarely. Significant numbers of
chorionic trophoblasts remain detectable, but they fail to un-
dergo terminal differentiation in the vicinity of the fetal blood
vessels. Maternal blood sinuses are dilated. No functional lab-
yrinth forms. At present, it is unclear whether GCMa, Tfeb,
and PPARg are members of the same differentiation pathway
and whether they are coordinately regulated during tropho-
blast differentiation. Expression studies of PPARg and Tfeb in
the mGCMa knockout (and vice versa) will clarify this issue.
Clearly different from the effects of mGCMa ablation are
the phenotypic manifestations of Esx1, Wnt-2, and hepatocyte
growth factor/scatter factor (HGF/SF) knockouts (24, 27, 30,
38). Compared to mGCMa, their effects become apparent only
at later times of embryonic development. The defects in the
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labyrinth layer are less severe. In the HGF/SF knockout, there
is a shortage of labyrinthine trophoblasts and a concomitant
increase of allantoic mesenchyme. As a consequence of this
unbalance, formation of the hemotrichorial barrier from tro-
phoblasts is disturbed (38). In the case of Esx1 and Wnt-2, the
fetal vasculature is affected, with reduced numbers of fetal
capillaries in the Wnt-2 knockout and aberrant branching pat-
terns in the Esx1 knockout (24, 27). In both latter cases, the
placenta is edematous and contains large pools of maternal
blood. In the Esx1-deficient mice, wedges of spongiotropho-
blast reach deep into the labyrinth layer, while giant cells can
be found in the Wnt-2 knockouts throughout the labyrinth all
the way to the chorionic plate. Comparable breaches of layer
integrity have never been observed in the mGCMa knockout.
What could be the function of mGCMa in trophoblasts? As
already mentioned, the pattern of mGCMa expression in cho-
rionic and later in labyrinthine trophoblasts is not indicative of
a role as a master regulator of the trophoblast fate. There are
many more cells that are positive for the trophoblast-specific
markers Dlx3 and GCNF in the early placenta than there are
mGCMa-expressing cells. Also, trophoblast fate is maintained
in the absence of mGCMa as evident from the persistence of
significant numbers of Dlx3- and GCNF-positive cells in the
mutant placenta.
Strikingly, mGCMa expression in labyrinthine trophoblasts
correlated well with their proximity to allantoic mesenchyme.
At the time of chorion-allantois fusion, all mGCMa-expressing
cells were found in the chorionic plate in close contact with the
allantois. In the Mrj mutant, loss of chorioallantoic fusion
correlated with a strong reduction in mGCMa expression (16).
Later, mGCMa-expressing cells started to appear in inner re-
gions of the placenta in close association with fetal blood
vessels, with the highest levels of expression in differentiated,
syncytial trophoblasts that surround the fetal blood vessels.
Thus, it is tempting to speculate that mGCMa is part of the
existing cross-regulation between allantoic mesenchyme and
extraembryonic ectoderm that is needed to fine-tune the de-
velopment of the labyrinth layer. Our results point to an in-
duction of mGCMa in chorionic trophoblasts in response to an
allantois-derived signal. The existence of such signals has been
documented during various phases of placental development.
Interaction of the vascular cell adhesion molecule 1 ligand on
allantoic mesenchyme with the a4 integrin receptor on chori-
onic trophoblast, for instance, is an important step during
chorion-allantois fusion (12). Later on, both Wnt-2 and
HGF/SF are secreted by allantoic mesenchyme and influence
development of the labyrinthine trophoblasts (27, 38).
In addition to induction of mGCMa in trophoblasts by al-
lantoic mesenchyme, we postulate a consecutive role for
mGCMa in trophoblast differentiation, mediating changes in
trophoblast gene expression that allow vasculogenesis and that
ultimately lead to the formation of the hemotrichorial barrier
around the fetal vessels. Such a model would be compatible
with most of our observations. It would explain the localization
of mGCMa- and lacZ-expressing cells. At the time of cho-
rioallantoic fusion, mGCMa- and lacZ-expressing cells would
first be confined to the contact zone at the base of the placenta.
Later, during the period of active vessel formation, mGCMa-
and lacZ-expressing cells would spread throughout the laby-
rinth of the normal placenta and dramatically increase in num-
ber concomitant with vasculogenesis. In the mutant placenta,
lacZ-expressing cells would also appear first at the base of the
placenta. Their failure to differentiate in the absence of
mGCMa would prevent the allantoic vessels from adequately
invading the prospective labyrinth and from expanding. The
base of the mutant placenta would remain the only site where
chorionic trophoblasts stay in contact with allantoic mesen-
chyme and would therefore be the only region that contains
lacZ-expressing trophoblasts in the mutant. This is indeed the
case. Because lacZ expression is lost in the mutant placenta
from 12.5 d.p.c. onwards, we furthermore have to postulate a
disappearance of the inducing mesenchymal signal. It is possi-
ble that the resorption of the mutant conceptus is the primary
cause for this disappearance. Alternatively, the allantois-de-
rived paracrine signal might normally be turned off at this time
of development and be replaced by a positive autoregulatory
feedback loop as has been shown to exist for Drosophila GCM
(26). Maintenance of mGCMa expression would then be de-
pendent on mGCMa itself, and absence of mGCMa in the
mutant would cause a gradual extinction of mGCMa expres-
sion. The existence of an autoregulatory mechanism and the
identification of additional downstream targets will be the fo-
cus of future experiments and will help us to understand
mGCMa function in the placenta. Whether mGCMa has an
additional role at later times during development or in the
adult will be clarified only once tetraploid rescue experiments
have been performed.
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